Provided by Tiger Trade Technology Pte. Ltd.

Salarius Pharmaceuticals Inc

0.8400
0.0000
Volume:- -
Turnover:4.69M
Market Cap:5.36M
PE:-0.02
High:0.8400
Open:0.8400
Low:0.8400
Close:0.8400
52wk High:108.00
52wk Low:0.5148
Shares:6.38M
Float Shares:6.34M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-39.1909
EPS(LYR):-86.9214
ROE:-139.55%
ROA:-69.91%
PB:1.26
PE(LYR):-0.01

Loading ...

Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX”

GlobeNewswire
·
Nov 20, 2025

Salarius Pharmaceuticals - Became Aware That Certain Financial Market Data Platforms Published That Co Had Been Delisted From Nasdaq

THOMSON REUTERS
·
Nov 18, 2025

BUZZ-Salarius jumps after completing merger with Decoy Therapeutics

Reuters
·
Nov 13, 2025

Press Release: Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger

Dow Jones
·
Nov 13, 2025

Crude Oil Dips 4%; On Holding Shares Jump After Q3 Earnings

Benzinga
·
Nov 13, 2025

Shoulder Innovations (SI) Stock Rose 21% After-Hours: Here's Why

Benzinga
·
Nov 12, 2025

Why Did RYTHM (RYM) Stock Jump Over 23% Overnight?

Benzinga
·
Nov 12, 2025

Why Did Salarius (SLRX) Shares Soar Over 23% After-Hours?

Benzinga
·
Nov 12, 2025

Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump

Benzinga
·
Nov 12, 2025

Salarius Pharmaceuticals Prices $7 Million Public Offering

MT Newswires Live
·
Nov 12, 2025

Salarius Pharmaceuticals Announces Pricing of $7 Million Underwritten Public Offering

THOMSON REUTERS
·
Nov 11, 2025

Salarius Pharmaceuticals Inc - Combined Offering Price per Share and Warrants Is $1.50

THOMSON REUTERS
·
Nov 11, 2025

Salarius Pharmaceuticals Awards $225,000 Transaction Bonus to Acting CEO Mark J. Rosenblum

Reuters
·
Oct 21, 2025

Salarius Pharmaceuticals Regains Full Nasdaq Compliance, Paving Way for Planned Merger with Decoy Therapeutics

Reuters
·
Oct 14, 2025

Salarius Pharmaceuticals Regains Compliance With All Nasdaq Listing Requirements

THOMSON REUTERS
·
Oct 13, 2025

Salarius Pharmaceuticals Raises $3.8 Million in Private Placement, Expects to Regain Nasdaq Compliance

Reuters
·
Oct 07, 2025

Wall Street Set to Open Higher Thursday; Jobless Claims Fall as Manufacturing Index Rebounds

MT Newswires Live
·
Sep 18, 2025

BRIEF-Salarius Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement

Reuters
·
Sep 09, 2025

Salarius Pharmaceuticals Announces Definitive Merger Agreement with Decoy Therapeutics to Form New Biopharmaceutical Company

Reuters
·
Sep 09, 2025

Salarius Pharmaceuticals Executes 1-for-15 Reverse Stock Split to Meet Nasdaq Compliance

Reuters
·
Aug 28, 2025